Skip to content

Cancer Health Center

Font Size

Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options by Stage

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

Stage I Mycosis Fungoides and the Sézary Syndrome

Recommended Related to Cancer

Leukemia, Hairy Cell

Important It is possible that the main title of the report Leukemia, Hairy Cell is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Read the Leukemia, Hairy Cell article > >

Treatment of stage I mycosis fungoides and the Sézary syndrome may include the following:

  • PUVA therapy with or without biologic therapy (interferon).
  • Radiation therapy to a single skin lesion or to all the skin on the body (TSEB).
  • Topical corticosteroid therapy.
  • Radiation therapy to skin lesions, as palliative therapy to reduce tumor size or relieve symptoms and improve quality of life.
  • Topical chemotherapy.
  • Biologic therapy (interferon) with or without topical chemotherapy.
  • Retinoid therapy.
  • Systemic chemotherapy.
  • Targeted therapy with a histone deacetylase (HDAC) inhibitor (vorinostat or romidepsin).
  • Targeted therapy with a monoclonal antibody (denileukin diftitox).
  • A clinical trial of ultraviolet B (UVB) radiation therapy.
  • A clinical trial of a new treatment.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Stage II Mycosis Fungoides and the Sézary Syndrome

Treatment of stage II mycosis fungoides and the Sézary syndrome is palliative (to relieve symptoms and improve the quality of life) and may include the following:

  • PUVA therapy with or without biologic therapy (interferon).
  • Radiation therapy to all the skin on the body (TSEB).
  • Topical corticosteroid therapy.
  • Topical chemotherapy.
  • Radiation therapy to skin lesions.
  • Biologic therapy (interferon) with or without topical chemotherapy.
  • Retinoid therapy.
  • Systemic chemotherapy.
  • Targeted therapy with a histone deacetylase (HDAC) inhibitor (vorinostat or romidepsin).
  • Targeted therapy with a monoclonal antibody (denileukin diftitox).
  • A clinical trial of ultraviolet B (UVB) radiation therapy.
  • A clinical trial of a new treatment.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage II mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Stage III Mycosis Fungoides and the Sézary Syndrome

Treatment of stage III mycosis fungoides and the Sézary syndrome is palliative (to relieve symptoms and improve the quality of life) and may include the following:

  • PUVA therapy with or without systemic chemotherapy.
  • PUVA therapy with or without biologic therapy (interferon).
  • Radiation therapy to all the skin on the body (TSEB).
  • Topical corticosteroid therapy.
  • Radiation therapy to skin lesions.
  • Systemic chemotherapy with one or more drugs, with or without topical chemotherapy.
  • Biologic therapy (interferon) with or without topical chemotherapy.
  • Extracorporeal photochemotherapy.
  • Topical chemotherapy.
  • Retinoid therapy.
  • Targeted therapy with a histone deacetylase (HDAC) inhibitor (vorinostat or romidepsin).
  • Targeted therapy with a monoclonal antibody (alemtuzumab or denileukin diftitox).
  • A clinical trial of ultraviolet B (UVB) radiation therapy.
  • A clinical trial of a new treatment.
1|2

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Colorectal cancer cells
A common one in both men and women.
Lung cancer xray
See it in pictures, plus read the facts.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article